Body composition and functional capacity in patients with Crohn's disease using Infliximab / Composição corporal e capacidade funcional de pacientes com doença de Crohn em uso de Infliximabe

Rationale: the use of anti-TNFα therapy, such as Infliximab (IFX), in patients with Chron's disease (CD) can lead to changes in body composition. Objective: to evaluate the body composition and functional capacity of patients with CD. Method: Cross-sectional study with patients with CD in clinical remission using IFX. For anthropometric evaluation, it was measured: weight, height and waist circumference; functional capacity by the hand grip strength test and body composition by bioelectric impedance. After that, the fat-free mass index and body fat index were calculated. Continouns variables were analyzed by Pearson or Spearman coefficient. For the multiple linear regression model, the time of use of IFX was used as a dependent variable and waist circumference, fat-free mass index, phase angle and handgrip strength were used as independent variables. Results: forty-three patients were evaluated, with an average of 43.1± 13.5 years of age. Of the total, 44.2% were overweight and 44.2% had increased waist circumference, 58.1% were classified with high to very high fat-free mass, 30.2% were below the adequacy parameter for fat-free mass index and 11.6% had reduced functional capacity. Conclusion: overweight, as well as increased waist circumference and body fat, is common in CD patients in clinical remission using Infliximab. Most patients had preserved functional capacity, however there wasn't association with time of use of IFX.

Introdução: o uso de terapia anti-TNFα, como o Infliximabe (IFX), em pacientes com doença de Chron (DC) pode levar a alterações na composição corporal. Objetivo: avaliar a composição corporal e capacidade funcional de pacientes com DC. Metodologia: estudo transversal com pacientes com DC em remissão clínica, em uso de IFX. Foi realizada avaliação antropométrica (peso, estatura e circunferência da cintura); avaliação de capacidade funcional (teste de força de pressão manual); e avaliação de composição corporal (impedância bioelétrica) com cálculo do índice de massa livre de gordura e índice de gordura corporal. Variáveis contínuas foram analisadas pelo coeficiente de correlação de Pearson ou Spearman. Para o modelo de regressão linear múltipla, o tempo de uso do IFX foi utilizado como variável dependente e circunferência da cintura, índice de massa magra, ângulo de fase e força de preensão manual foram utilizados como variáveis independentes. Resultados: foram avaliados 43 pacientes, com média de idade de 43,1± 13,5 anos. 44,2% estavam acima do peso e 44,2% possuíam circunferência da cintura aumentada, 58,1% foram classificados com índice de gordura corporal de alto a muito alto, 30,2% estavam abaixo do parâmetro de adequação para o índice de massa livre de gordura e 11,6% apresentaram capacidade funcional reduzida. Conclusão: o excesso de peso e o aumento de circunferência da cintura e gordura corporal é frequente em pacientes com DC em remissão clínica e em uso de IFX. A maioria dos pacientes apresentou capacidade funcional preservada, porém não houve associação com o tempo de uso do IFX.

Phytochemicals and Biological Activities of Burdock (Arctium lappa L.) Extracts: A Review.

Arctium lappa L., also known as burdock, is an edible wild plant which has the ability to grow in distinct environments and is considered a weed in several parts of the world. This species has great value in the biological and medical fields with its major secondary components being phenolic compounds and terpenes, substances rich in desired biological activities as antioxidant, antimicrobial, antitumor and anti-inflammatory. In addition, burdock leaves extracts have shown a modulatory effect on the complement system, which plays an important role in the development of inflammatory diseases, with an inhibitory effect on all complement pathways. Thus, natural products with those relevant activities are promising agents for healthcare applications. Therefore, the species A. lappa may represent an interesting asset for researching and developing new therapies for inflammatory afflictions.

Bioactive Secondary Plant Metabolites from Euphorbia umbellata (PAX) BRUYNS (Euphorbiaceae).

The species Euphorbia umbellata has been used to treat inflammatory diseases, cancer, and ulcers. Biological activities reported in the literature, including antiproliferative, cytotoxic and anti-inflammatory, are attributed to the chemical constituents present in its composition as terpenes and polyphenolic compounds. The most recurrently verified metabolites in the Euphorbiaceae family plant species are terpenes, of which euphol is a major constituent with broadly reported cytotoxic, antinociceptive and anti-inflammatory effects; it frequently appears in various extracts obtained from the plant. Euphol has a documented inhibitory effect on neutrophil chemotaxis and can modulate the complement system. Since complement system activation is intimately intertwined with autoimmune and inflammatory diseases, tumor growth promotion and metastasis, plant metabolites from Euphorbia umbellata might influence the outcomes of inflammatory processes. We believe that this is the first review presenting the current knowledge on Euphorbia umbellata secondary metabolites and their biological activities.

Evaluation of the Lectin Pathway in the Serum of Patients with Chronic Chagas Disease by Detection of C4 by Elisa / Avaliação da via das lectinas no soro de pacientes com doença de Chagas crônica pela detecção de C4 por Elisa

ABSTRACT Chagas disease (CD) is a chronic tropical disease caused by Trypanosoma cruzi , affecting about 8 million people in Latin America. The lectin pathway (LP) of the complement system is one of the first lines of host defense in the response against T. cruzi , and can continue to be activated in chronic infection due to the escape of the parasite to its action. Although some components of this pathway have been investigated in CD, there are no reports on its activation in patient serum. In this context, our objective was to evaluate the activation of LP in chronic chagasic patients and controls by the detection of the C4 component, using the direct ELISA assay. For this purpose, serum of 80 patient with chronic CD (clinical forms: asymptomatic n=17; symptomatic n=63; cardiac n=45; cardio digestive n=13; digestive n=5) followed at the Ambulatory of Attention to Chagasic Patients (HC/UFPR) and 80 healthy controls (donors of the Blood Bank of HC) were evaluated regarding the evaluation of the LP. The results showed that LP activation by mannose-binding lectin (MBL) was found reduced while activation by ficolins was increased in patients with CD when compared to controls. The same results were observed when the patients were categorized according to the indeterminate and symptomatic clinical forms. We conclude that the detection of the C4 component by ELISA is an efficient methodology to assess LP activation in serum from patients with chronic CD, enabling to differentiate the activation profile between patients and controls..

RESUMO A doença de Chagas (DC) é uma doença tropical crônica causada pelo Trypanosoma cruzi, atingindo cerca de 8 milhões de pessoas na América Latina. A via das lectinas (VL) do sistema complemento é uma das primeiras linhas de defesa na resposta imunológica contra a infecção pelo T. cruzi, e pode continuar sendo ativada na infecção crônicadevido ao escape do parasito à sua ação. Embora alguns componentes dessa via tenham sido investigados na DC, não existem relatos sobre sua ativação em soro de pacientes. Neste contexto, nosso objetivo foi avaliar a ativação da VL no soro de pacientes com DC crônica e controles pela detecção do componente C4 empregando a técnica de ELISA. Para isso, amostras de soro de 80 pacientes com DC crônica (formas clínicas: indeterminada n=17; sintomática n=63; cardíaca n=45; cardiodigestiva n=13; digestiva n=5) atendidos no Ambulatório de Atenção ao Paciente Chagásico (HC/UFPR) e 80 controles saudáveis (doadores do Banco de Sangue do HC) foram avaliados quanto a ativação da VL. Os resultados demonstraram que a ativação da VL pela lectina ligante de manose (MBL) encontra-se reduzida, enquanto que a ativação pelas ficolinas está aumentada em pacientes com DC quando comparados aos controles. Os mesmos resultados foram observados quando os pacientes foram categorizados quanto às formas clínicas indeterminada e sintomática. Concluímos que a detecção do componente C4 por ELISA é uma metodologia eficiente para avaliar a ativação da VL em soro de pacientes com DC crônica possibilitando diferenciar o perfil de ativação entre pacientes e controles.

HOW IS THE DIET QUALITY OF PATIENTS WITH CROHN'S DISEASE IN CLINICAL REMISSION USING INFLIXIMAB?

BACKGROUND: A healthy diet is recommended for patients with Crohn's disease (CD) in remission. OBJECTIVE: To evaluate the diet quality of patients with CD. METHODS: Cross-sectional study with patients with CD and clinical remission using the biological agent infliximab. The diet quality was assessed using the Diet Quality Index-Revised (DQI-R). DQI-R was calculated based on 24-hour dietary recalls (24HR), being classified as "inadequate diet" (≤40 points), "diet requiring modifications" (41 to 64 points) and "healthy diet" (≥65 points). Weight, height and waist circumference (WC) of patients were assessed. For comparison between groups, Student's t-test or Mann-Whitney was used. For correlation between continuous variables, Pearson or Spearman coefficient was used. Values of P<0.05 indicated statistical significance. RESULTS: A total of 43 patients participated in the study. The final DQI-R score was 49.1 points - "diet requiring modifications". No patient received the classification of "healthy diet" (maximum score =59.7), 55.8% presented "diet requiring modifications" and 44.2% "inadequate diet". When comparing the "inadequate diet" and "diet requiring modifications" groups, a lower mean age was observed in the "inadequate diet" group (37.6±14.8 versus 47.4±10.5 y, P=0.02). It was found that 44.2% of the patients were overweight (body mass index [BMI] ≥25 kg/m²) and had increased WC (women: WC ≥80 cm and men: WC ≥94 cm). A positive correlation was found between the final DQI-R score and BMI (P=0.046; r=0.346). CONCLUSION: Patients with CD in clinical remission using infliximab are not adopting a diet considered healthy, which points to the need for an individualized nutritional approach.

Como está a qualidade da dieta de pacientes com doença de Crohn em remissão clínica e em uso de infliximabe? / How is the diet quality of patients with crohn's disease in clinical remission using infliximab?

ABSTRACT BACKGROUND: A healthy diet is recommended for patients with Crohn's disease (CD) in remission. OBJECTIVE: To evaluate the diet quality of patients with CD. METHODS: Cross-sectional study with patients with CD and clinical remission using the biological agent infliximab. The diet quality was assessed using the Diet Quality Index-Revised (DQI-R). DQI-R was calculated based on 24-hour dietary recalls (24HR), being classified as "inadequate diet" (≤40 points), "diet requiring modifications" (41 to 64 points) and "healthy diet" (≥65 points). Weight, height and waist circumference (WC) of patients were assessed. For comparison between groups, Student's t-test or Mann-Whitney was used. For correlation between continuous variables, Pearson or Spearman coefficient was used. Values of P<0.05 indicated statistical significance. RESULTS: A total of 43 patients participated in the study. The final DQI-R score was 49.1 points - "diet requiring modifications". No patient received the classification of "healthy diet" (maximum score =59.7), 55.8% presented "diet requiring modifications" and 44.2% "inadequate diet". When comparing the "inadequate diet" and "diet requiring modifications" groups, a lower mean age was observed in the "inadequate diet" group (37.6±14.8 versus 47.4±10.5 y, P=0.02). It was found that 44.2% of the patients were overweight (body mass index [BMI] ≥25 kg/m²) and had increased WC (women: WC ≥80 cm and men: WC ≥94 cm). A positive correlation was found between the final DQI-R score and BMI (P=0.046; r=0.346). CONCLUSION: Patients with CD in clinical remission using infliximab are not adopting a diet considered healthy, which points to the need for an individualized nutritional approach.

RESUMO CONTEXTO: É recomendado alimentação saudável para pacientes com doença de Crohn (DC) em remissão. OBJETIVO: Avaliar a qualidade da dieta de pacientes com DC. MÉTODOS: Estudo transversal com pacientes com DC em remissão clínica e em uso do imunobiológico infliximabe. A qualidade da dieta foi avaliada pelo índice de qualidade da dieta revisado (IQD-R). O IQD-R foi calculado a partir do recordatório 24 horas, sendo classificado em "dieta inadequada" (≤40 pontos), "dieta que requer modificações" (41 a 64 pontos) e "dieta saudável" (≥65 pontos). Os pacientes foram avaliados quanto ao peso, altura e circunferência da cintura (CC). Para comparação entre grupos foi utilizado o test-t de Student ou Mann-Whitney. Para correlação entre variáveis contínuas foi utilizado o coeficiente de Pearson ou Spearman. Valores de P<0,05 indicaram significância estatística. RESULTADOS: Participaram do estudo 43 pacientes. A pontuação final do IQD-R foi de 49,1 pontos - "dieta que requer modificações". Nenhum paciente recebeu a classificação de "dieta saudável" (pontuação máxima =59,7), 55,8% apresentaram "dieta que requer modificações" e 44,2% "dieta inadequada". Ao comparar os grupos "dieta inadequada" e "dieta que requer modificações", foi observado menor média de idade no grupo "dieta inadequada" (37,6±14,8 versus 47,4±10,5 anos, P=0,02). Verificou-se que 44,2% dos pacientes estavam acima do peso (índice de massa corporal (IMC) ≥25 kg/m²) e possuíam CC aumentada (mulheres: CC ≥80 cm e homens: CC ≥94 cm). Foi encontrada correlação positiva entre a pontuação final do IQD-R e o IMC (P=0,046; r=0,346). CONCLUSÃO: Os pacientes com DC em remissão clínica e em uso de infliximabe não estão adotando dieta com qualidade considerada saudável o que aponta a necessidade de abordagem nutricional individualizada.

Immunomodulatory and cytotoxic activities of euphol.

AIMS: This study evaluated the effect of euphol isolated from Euphorbia umbellata (Pax) Bruyns latex on the activation of complement pathways (classical (CP), alternative (AP) and lectin (LP)), neutrophil chemotaxis, cytotoxic activity, cell morphology and death in HRT-18 and 3T3 cells lines. MAIN METHODS: CP and AP were assessed using hemolytic assays and ELISA for LP; neutrophil chemotaxis was performed using Boyden's chamber; cytotoxicity was evaluated by neutral red methodology and characteristics of cell death were assessed by cell morphology with hematological staining. KEY FINDINGS: Although euphol increased CP activation (38% at a concentration of 976.1 µM), an inhibitory effect on AP, LP (31% and 32% reduction in the concentration of 976.1 µM) and neutrophil chemotaxis (inhibit 84% of neutrophil migration at a concentration 292.9 µM) was observed. In addiction euphol was able to induce significant cell death in a time-dependent manner, presenting an IC50 of 70.8 µM and 39.2 µM for HRT-18 and 3T3 cell lines respectively and it was also observed apoptotic characteristics as cellular rounding, chromatin condensation and blebs formation for both cell lines. SIGNIFICANCE: Euphol has a potential use for the treatment of complement-related inflammatory diseases due to its ability to downregulate inflammation. On the other hand, the controlled activation of CP can contribute to complement-dependent cytotoxicity in the context of monoclonal antibody-based cancer treatment.

Effects of Euphorbia umbellata extracts on complement activation and chemotaxis of neutrophils.

ETHNOPHARMACOLOGICAL RELEVANCE: The species Euphorbia umbellata (leitosinha) has been traditionally used for the treatment of inflammatory diseases and cancer. AIM OF THE STUDY: Evaluation the effect of E. umbellata latex extracts obtained with hexane, chloroform, ethyl acetate and methanol on the activation of the complement pathways and neutrophil chemotaxis. MATERIALS AND METHODS: The latex was partitioned using Soxhlet apparatus and hexane, chloroform, ethyl acetate and methanol as solvents. The classical and alternative pathway activity were performed by hemolytic assays with sensitized sheep or rabbit erythrocytes, respectively; the lectin pathway activity was quantified by ELISA, through the measurement of C4 molecules and the chemotaxis of human neutrophils was performed using 1% casein as the chemotactic inducer and Boyden's chamber. GC-Q-ToF and NMR analyses were applied to evaluate the chemical composition of E. umbellata latex extracts. RESULTS: All E. umbellata latex extracts exhibited an inhibitory effect on the activation of the alternative pathway. Methanol and ethyl acetate extracts inhibited the classical pathway while chloroform extract activated this pathway. Ethyl acetate and hexane extracts inhibited lectin activation. All E. umbellata extracts inhibited casein-induced neutrophil chemotaxis. Terpenes and phenolic compounds have been suggested to be present in the E. umbellta latex extracts. CONCLUSION: The E. umbellata latex was able to modulate the functions of the immune system. Thus, it is possible to infer that the terpenes and phenolic compounds of the phytocomplex of E. umbellata latex can contribute for the activity on the complement pathways.

Inhibitory Effect of Supercritical Extracts from Arctium lappa L. on the Lectin Pathway of the Complement System.

The complement system participates in host defense by eliminating microorganisms and triggering inflammation. However, insufficient control or exacerbated complement activation contributes to inflammatory diseases. Since promising antioxidant and anti-inflammatory activities have been identified in Arctium lappa L. extracts, this study aims to explore the effect of A. lappa extracts on the lectin pathway (LP) of complement activation. Four extracts were obtained by supercritical extraction using scCO2 with or without ethanol as co-solvent, at different temperatures and pressures (E1: 2.2 mg/mL, E2: 2.6 mg/mL and E3: 2.0 mg/mL, E4: 1.5 mg/mL). To evaluate the effect of A. lappa extracts on the LP activation, an ELISA assay using mannose binding lectin pathway of complement was carried out with C4 detection. All extracts showed a concentration-dependent inhibitory effect on the activation of complement by the LP. The following IC50 were observed for E1, E2, E3 and E4: 179.4 µg/mL, 74.69 µg/mL, 119.1 µg/mL and 72.19 µg/mL, respectively. Our results suggest that A. lappa extracts are potential candidates for the treatment of inflammatory disorders that are complement-related.

Perioperative and survival outcomes of laparoscopic radical cystectomy for bladder cancer in patients over 70 years.

INTRODUCTION: Radical cystectomy in elderly patients is a controversial issue that has noticed an increase in importance overtime because of the lengthening average life span. Our objective was to determine if there were significant differences in the perioperative outcomes of patients over 70 years with bladder cancer treated with laparoscopic radical cystectomy (LRC) compared to those of younger patients. MATERIAL AND METHODS: We selected 180 patients who underwent LRC in our department in the period between 2005-2012. We divided them into 2 groups: 57% <70 years and 43% >70 years, and we compared the different parameters such as: comorbidities, intraoperative and post-operative complications, TNM stage and overall survival. RESULTS: The group <70 years had less comorbidities when compared with the group >70 years. Heterotopic urinary diversion was the diversion of choice in the elderly patients (97.4%). Paralytic ileus and the worsening of renal function were the only complications with statistical differences between the groups. Mean hospital length of stay was not significantly different between the groups. Younger and older patients had similar pathological staging : pT1 or less: 26,2 vs. 18.2%, pT2: 19.4 vs. 16.9%, pT3 38.8 vs. 37.7% and pT4 15.6 vs. 17.2%. Kaplan-Meier curves did not show significant differences in survival. CONCLUSIONS: Laparoscopic radical cystectomy in the elderly patient has similar rates of perioperative morbidity when compared with the younger patient and may be offered as a treatment option in selected elderly patients.

Atividade dos músculos masseter e temporal em relação às características miofuncionais das funções de mastigação e deglutição em obesos / Activity of masseter and temporal muscles in relation to the myofunctional characteristics of chewing and swallowing functions in obese

Objetivo: Este estudo teve como objetivo relacionar a atividade elétrica dos músculos masseter e temporal com as características miofuncionais das funções mastigação e deglutição de crianças e adolescentes obesos. Métodos: Foram selecionados 28 obesos participantes do Ambulatório de Obesidade do HUSM, sendo coletadas as características miofuncionais através do Protocolo de Avaliação Miofuncional com Escores (AMIOFE) e a eletromiografia dos músculos masseter e temporal durante a mastigação e deglutição. Os dados eletromiográficos foram normalizados utilizando-se a média da máxima intercuspidação de cada músculo estudado nas avaliações realizadas. Resultados: A mastigação na maioria dos obesos foi bilateral e a média da atividade elétrica dos músculos avaliados foi superior em relação aos que utilizam preferencialmente a mastigação unilateral, com exceção do músculo temporal esquerdo. Durante a deglutição, a atividade elétrica dos músculos masseter e temporal não apresentou diferença significante em relação às características miofuncionais. Conclusão: Pode-se evidenciar que independente das características miofuncionais de crianças e adolescentes obesos existe semelhança durante a mastigação e deglutição na ativação dos músculos masseter e temporal.(AU)

Purpose: This study aimed to relate the electrical activity of the masseter and temporal muscles to the myofunctional characteristics of chewing and swallowing function in children and adolescents. Methods: We selected 28 obese participants in the Obesity Clinic of the HUSM, being the myofunctional characteristics collected through the Assessment Protocol Myofunctional with scores (AMIOFE) and electromyography of masseter and temporal muscles during chewing and swallowing. The EMG data were normalized using the mean of maximal intercuspation of each muscle studied in the assessments. Results: The majority of the masticatory obese was bilateral and the average electrical activity of muscles tested was superior to that used in preference to unilateral mastication except the left temporal muscle. During swallowing, the electrical activity of masseter and temporal muscles showed no significant difference in relation to myofunctional characteristics. Conclusion: It is evident that regardless of myofunctional characteristics of obese children and adolescents, during chewing and swallowing exists similarity in the activation of the masseter and temporal muscles.(AU)

Objetivo: El presente estudio tuvo como objetivo relacionar la actividad eléctrica de los maseteros y temporales con las características miofuncionales de las funciones de masticar y tragar en niños y adolescentes obesos. Métodos: Se seleccionaron 28 participantes obesos en la Clínica de Obesidad del HUSM. Las características miofuncionales fueron recogidas a través del Protocolo de Evaluación Miofuncional con Escores (puntuaciones) (AMIOFE) y de electromiografía de los músculos massater y temporal, durante la masticación y la deglución. Los datos electromiográficos se normalizaron con la media de intercuspidación máxima de cada músculo estudiado en las evaluaciones. Resultados: En la mayoría de los obesos la masticación fue bilateral y la actividad eléctrica media de los músculos probados fue superior a la utilizada por aquellos que dieron preferencia a la masticación unilateral excepto el músculo temporal izquierdo. Durante la deglución, la actividad eléctrica de los músculos maseteros y temporales no mostró diferencias significativas en relación a las características miofuncionales.(AU)Conclusión: Quedó evidente que, independientemente de las características miofuncionales delos niños y adolescentes obesos, existe similitud durante la masticación y la deglución en la activaciónde los músculos masetero y temporal.(AU)

Atividade dos músculos masseter e temporal em relação às características miofuncionais das funções de mastigação e deglutição em obesos / Activity of masseter and temporal muscles in relation to the myofunctional characteristics of chewing and swallowing functions in obese

Objetivo: Este estudo teve como objetivo relacionar a atividade elétrica dos músculos masseter e temporal com as características miofuncionais das funções mastigação e deglutição de crianças e adolescentes obesos. Métodos: Foram selecionados 28 obesos participantes do Ambulatório de Obesidade do HUSM, sendo coletadas as características miofuncionais através do Protocolo de Avaliação Miofuncional com Escores (AMIOFE) e a eletromiografia dos músculos masseter e temporal durante a mastigação e deglutição. Os dados eletromiográficos foram normalizados utilizando-se a média da máxima intercuspidação de cada músculo estudado nas avaliações realizadas. Resultados: A mastigação na maioria dos obesos foi bilateral e a média da atividade elétrica dos músculos avaliados foi superior em relação aos que utilizam preferencialmente a mastigação unilateral, com exceção do músculo temporal esquerdo. Durante a deglutição, a atividade elétrica dos músculos masseter e temporal não apresentou diferença significante em relação às características miofuncionais. Conclusão: Pode-se evidenciar que independente das características miofuncionais de crianças e adolescentes obesos existe semelhança durante a mastigação e deglutição na ativação dos músculos masseter e temporal.

Purpose: This study aimed to relate the electrical activity of the masseter and temporal muscles to the myofunctional characteristics of chewing and swallowing function in children and adolescents. Methods: We selected 28 obese participants in the Obesity Clinic of the HUSM, being the myofunctional characteristics collected through the Assessment Protocol Myofunctional with scores (AMIOFE) and electromyography of masseter and temporal muscles during chewing and swallowing. The EMG data were normalized using the mean of maximal intercuspation of each muscle studied in the assessments. Results: The majority of the masticatory obese was bilateral and the average electrical activity of muscles tested was superior to that used in preference to unilateral mastication except the left temporal muscle. During swallowing, the electrical activity of masseter and temporal muscles showed no significant difference in relation to myofunctional characteristics. Conclusion: It is evident that regardless of myofunctional characteristics of obese children and adolescents, during chewing and swallowing exists similarity in the activation of the masseter and temporal muscles.

Objetivo: El presente estudio tuvo como objetivo relacionar la actividad eléctrica de los maseteros y temporales con las características miofuncionales de las funciones de masticar y tragar en niños y adolescentes obesos. Métodos: Se seleccionaron 28 participantes obesos en la Clínica de Obesidad del HUSM. Las características miofuncionales fueron recogidas a través del Protocolo de Evaluación Miofuncional con Escores (puntuaciones) (AMIOFE) y de electromiografía de los músculos massater y temporal, durante la masticación y la deglución. Los datos electromiográficos se normalizaron con la media de intercuspidación máxima de cada músculo estudiado en las evaluaciones. Resultados: En la mayoría de los obesos la masticación fue bilateral y la actividad eléctrica media de los músculos probados fue superior a la utilizada por aquellos que dieron preferencia a la masticación unilateral excepto el músculo temporal izquierdo. Durante la deglución, la actividad eléctrica de los músculos maseteros y temporales no mostró diferencias significativas en relación a las características miofuncionales.(AU)Conclusión: Quedó evidente que, independientemente de las características miofuncionales delos niños y adolescentes obesos, existe similitud durante la masticación y la deglución en la activaciónde los músculos masetero y temporal.

Características miofuncionais de obesos respiradores orais e nasais / Myofunctional characteristics of obese mouth and nose breathers

OBJETIVO: Investigar as características miofuncionais de obesos respiradores orais e nasais. MÉTODOS: Foram selecionados por conveniência 24 obesos, com idades entre 8 e 15 anos, pertencentes ao Grupo de Obesidade do Ambulatório de Pediatria de um Hospital Universitário. As características miofuncionais foram avaliadas por meio do protocolo de Avaliação Miofuncional Orofacial com Escalas (AMIOFE). RESULTADOS: Foi observada respiração oral em 62,5%, e respiração nasal em 37,5% da população estudada. No grupo de respiradores orais, 40% apresentaram oclusão com tensão dos lábios e 80% palato com largura diminuída, enquanto que quase todos os respiradores nasais tinham palato e lábios com postura normal. Interposição da língua nos arcos dentários ocorreu em 47% dos respiradores orais e em nenhum dos respiradores nasais. Os respiradores orais mostraram tendência em não repetir a deglutição de um mesmo bolo alimentar. A aparência da face, condição postural da mandíbula, bochechas e função de mastigação foram semelhantes nos dois grupos. CONCLUSÃO: A respiração oral em crianças e adolescentes obesos foi acompanhada de alterações miofuncionais do sistema estomatognático, representadas por diminuição da largura do palato, interposição da língua aos arcos dentários, oclusão dos lábios com tensão e alteração da deglutição.

PURPOSE: To investigate the myofunctional characteristics of nasal and oral breathing in obese individuals. METHODS: Participants were 24 obese individuals with ages between 8 and 15 years, who participated in the Obesity Group of the Ambulatory of Pediatrics of an University Hospital, and were selected by convenience. The myofunctional characteristics were assessed using the Orofacial Myofunctional Assessment with Scales (Avaliação Miofuncional Orofacial com Escalas - AMIOFE) protocol. RESULTS: Oral breathing was present in 62.5%, and nasal breathing in 37.5% of the population studied. In the oral breathing group, 40% of the subjects presented lips tension during occlusion and 80% showed a narrow palate, while almost all nasal breathers had normal palate and lips posture (p<0.05). Interposition of the tongue in the dental arches occurred in 47% of oral breathers and none of the nasal breathers. Oral breathers showed the tendency not to repeat the swallowing of the same bolus. No difference was found between groups regarding face appearance, jaw posture, cheeks, and chewing function. CONCLUSION: Oral breathing in obese children and adolescents was accompanied by myofunctional alterations of the stomatognathic system, represented by narrow palate, interposition of the tongue in the dental arches, occlusion of the lips with tension, and swallowing disorders.

Saturación sensorial y lactancia materna como métodos analgésicos no farmacológicos: estudio randomizado controlado / Sensory overload and breastfeeding as analgesic method no pharmacologic: control randomized study

OBJETIVO: Verificar el efecto analgésico de la saturación sensorial (Sat) y compararlo con la lactancia materna (LM) y un grupo control. MATERIAL Y MÉTODOS: Ensayo clínico, randomizado con 167 recién nacidos a término sanos, en quiénes se cuantificó la intensidad de dolor agudo al recibir una vacuna (hepatitis B) a las 48 horas de vida. Se formaron tres grupos de manera aleatoria: grupo 1 (control, sin método analgésico), grupo 2 (analgesia con LM) y grupo 3 (analgesia con Sat); los estímulos sensoriales fueron: táctil (caricias de la madre sobre el rostro y espalda), olfatorio (colonia sin alcohol), auditivo (voz de la madre), gustativo (lactancia materna), visual (rostro de la madre frente a su bebé). Se utilizó la Escala para Dolor Agudo Neonatal (DAN: Douleur Aiguë du Nouveau-né), con un score de dolor del 1 al 10 y 7 categorías de dolor. RESULTADOS: El grupo con saturación sensorial tuvo menos dolor (3.02 en la escala de DAN); el grupo dos (lactancia materna): 4.15, y control: 9.02. Hubo diferencia significativa entre grupos. Dolor extremo, se presentó en 60% del grupo control, 3,8% en el grupo lactancia materna y 0% en el grupo con saturación sensorial. La categoría NO DOLOR fue más frecuente en el grupo tres (Sat): 33,3% versus 16,9% del grupo con LM y 0% grupo control, p<0.0001. CONCLUSIONES: La saturación sensorial tuvo mayor efecto analgésico que la lactancia materna. Ambas demostraron buen efecto analgésico, comparadas con el grupo control.

OBJECTIVES: To verify the analgesic effect of sensory overload (SO) and compared with breastfeeding (BF) and a control group. MATERIAL AND METHODS: We conducted a randomized clinical trial in 167 healthy term infants, in which the intensity acute pain was quantified to receive hepatitis B vaccine within 48 hours of life. Three groups were formed at random: one group (control, no method of analgesia), group two (analgesia with BF) and group three (analgesia with SO), sensory stimuli were: touch (petting of the mother on baby face and back), olfactory (colony nonalcoholic), auditory (motherÆs voice), gustatory (breastfeeding), visual (mother and baby - face to face). We used the Neonatal Acute Pain Scale (DAN: Douleur Aigue du Nouveau-né), which gives a pain score of 1 to 10, giving 7 categories of pain. RESULTS: In group three (sensory overload) expressed less pain with an average score of 3.02 on the scale of DAN, the group two (breastfeeding): 4.15, and one group (control): 9.02, with significant difference between groups. The category of extreme pain occurred in 60% of the control group, 3.8% of the breastfed group and there was not extreme pain in the sensory overload group. NO PAIN category was more frequent in all three group (Sat): 33.3% versus 16.9% (group LM) and 0% (control group), p <0.0001. CONCLUSIONS: The sensory overload has greater analgesic effect of breastfeeding. Both demonstrate good analgesic effect compared with the control group.